For many, an anniversary presents an obvious time to reflect on the past—what’s been accomplished, where you’ve been, memories you’ve had. For me, MPO’s 15th anniversary is an unusual situation. While I was writing about the industry at that time, my coverage focus as editor of another magazine was decidedly on the design engineer as the target reader. I knew of outsourcing, but it really was like an entirely different entity from what I was covering. I do remember, however, when MPO debuted (then by its full name of Medical Product Outsourcing). Speaking with a colleague at the time, we knew they had nailed it as the direction the industry was headed even then was in flux—you know, when “no one was outsourcing anything.” Yeah, right.

So, in the interest of reminiscing about those early days of MPO, I went to the man who’s captained the ship since even before that first issue debuted. Group Publisher Howard Revitch pulled out the first two issues of the magazine from that first year so I could take a look back. Having worked with Howard for more than two years now, it was easy to identify how much his fingerprints were all over those early issues. Perhaps not directly, but the spirit and themes he values are very much present in those 2003 issues.

For example, one needs to look no further than the Editor’s Letter in the debut issue, written by then editor Andy Teng. “Each issue will key in on important trends affecting medical device and in-vitro diagnostic contract manufacturing, which, until now, have received scant coverage. Our goal is to offer relevant insight for OEMs and their outsource partners to best respond to today’s dynamic changes. A healthy mix of staff-written articles and industry professional-contributed stories provides balance and insight to our editorial lineup.” That recipe is still true today and can be heard coming from the mouth of Howard whenever anyone brings up the content or editorial focus of the magazine. New avenues for the delivery of that message have since emerged, such as the brand’s website (which debuted alongside the print magazine), enewsletter, social media accounts, and educational conference events, but the targeted focus has been maintained—something upon which Howard remains vigilant.

In fact, Howard’s message to readers in that debut issue is still something he is able to state today. “It is with great pleasure that I introduce Medical Product Outsourcing—the first and only publication dedicated 100% to the outsourcing of medical device and in-vitro diagnostic products.”He continued in that presentation to highlight the targeted content of MPO, “It will cover all aspects of medical device and IVD outsourcing, from partnership issues to regulatory concerns to design and manufacturing complexities.” And after 15 years of presenting this type of information to the industry, Howard (and myself alike) still enjoys learning of new dynamics that impact this fantastic industry.

Another aspect I found particularly interesting in those early issues was a feature titled “The Outlook on Outsourcing.” This article provided the results of a survey conducted by management consulting firm PRTM. The company had reached out to more than 40 of the world’s top medical device companies at the time to gain their insights and responses. It was interesting to see how many of the responses still rang true with device makers of today.

One question inquired about OEMs’ reasons for outsourcing. The top responses given were “Access to Technology (63 percent),” “Speed to Market (50 percent),” and “Reduce/Eliminate Overhead (47 percent).” The only changes today to those responses would likely be that more of the companies would cite those reasons, increasing the percentages.

Another percentage that would likely increase significantly if posed today was the response to the question regarding how long companies had worked with contract manufacturers. The top answer, at 63 percent, was “more than 5 years.” Now, you’d need a completely different range of answers, with the last option as “more than 20 years.”

Another relevant question that still mirrors the issues of today’s outsourcing relationship was one on the success factors in a contract manufacturing relationship. “Accumulated Experience (87 percent),” “Extensive Communications (81 percent),” “’Partnership Mentality’ (71 percent),” and “Trust (61 percent)” (which, in my opinion, seems low) were the top responses. Again, today would likely produce similar results if such a survey were conducted. Most interesting to me, however, is that the “partnership” dynamic was in play even back then. OEMs weren’t seeking part providers, but rather solution partners with which to collaborate.

Looking back through these issues from 2003 only strengthens my belief in the cliché, “The more things change, the more they stay the same.”

Related Editorial

According to Grand View Research, the global medical device outsourcing market was valued at $94.2 billion last year and is anticipated to grow at a very healthy 10.5 percent CAGR through 2026. That analysis includes contract manufacturing, regulator…

Anyone who has already seen the documentary running on HBO, “The Inventor: Out for Blood in Silicon Valley,” will likely recognize the phrase I used as the headline for this issue’s Letter. While it’s not new or unique to that…

Unless you’ve gone willfully about without reading any news, watching television, surfing the internet, or speaking with colleagues, you’ve undoubtedly heard about the growing skills gap (or labor shortage or whatever other term you want…

In my last Editor’s Letter, one of my “holiday wish list” items for 2019 was an improved industry image. To the general public, that includes the FDA and its oversight and regulations tied to medical devices. As such, efforts to enh…

Change is not typically something many have an easy time with. I know for me personally, it can present a challenge. The changing of clocks after Halloween, for example, can be a bit depressing as the days seem to shorten very quickly. It’s alw…

It’s unbelievable to realize I’m once again writing an end-of-the-year Editor’s Letter; 2018 seemed to pass by in a blur. All good things…well, you know.
The timing does, however, offer the opportunity to consider my 2018…

Recently, I watched the controversial medical device industry documentary, “The Bleeding Edge,” featured on Netflix. For those who have not had the opportunity to view it, I would certainly encourage you to do so. I would also encourage y…

What was I just saying in my Letter last issue? The more things change…? Well, it holds true going forward in this issue too—our annual Top Companies report. This expansive offering provides an in-depth look at the happenings within the…

“Help! I’ve fallen and I can’t get up.” That phrase represents the first experience or familiarity many people have with a voice-enabled medical device. In reality, the Life Alert system is triggered by a button worn around th…

Now, perhaps more than ever before, there are significant changes occurring to the worldwide regulatory landscape, all within a relatively small window. This includes FDA, the EU’s MDR, Asia (see the article in this issue on India’s new r…

Additive manufacturing has already made a significant impact in the area of medical device manufacturing, but what we’ve experienced thus far could merely be the tip of the iceberg. I’ve spoken to members of the industry about what I fore…

I considered writing this Letter on the passage of the legislation that suspends the medical device excise tax for another two years (literally just happened last night, at the time I’m writing this), but since we’ve already been down tha…

It seems like only yesterday I was writing my very first publisher’s letter back in 2003. It’s hard to believe we are about to celebrate 15 years of publishing MPO in 2018.
Just like in 2003, I still enjoy reflecting on hig…

That headline is immediately identifiable by many as it has become synonymous with the financial crisis of 2008. The phrase was then made in reference to the banks some thought had grown too large to be allowed to follow Lehman Brothers’ lead a…

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies. You can obtain detailed information about the use of cookies on our website by clicking on "More information”.